North west general hospital

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Fatty liver disease (MASLD/MASH)
• Type 2 diabetes

Running trials

• Recruiting

  Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

  NCT05644717· Phase 4· Getz Pharma· Source

  Contact: Arshad Hussain, M.B.B.S

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting
• Type 2 diabetes1 recruiting